SynAct Pharma AB (SYNACT) — Capital Reinvestment Ratio
Latest as of June 2019:
0.22x
SynAct Pharma AB (SYNACT) has a Capital Reinvestment Ratio of 0.22x as of June 2019, meaning it reinvests 0% of its operating cash flow (Skr1.77 Million) in capital expenditures (Skr394.90K). See SYNACT net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.22x
Capex / Operating Cash Flow
Operating Cash Flow
Skr1.77 Million
SEK
Capital Expenditures
Skr394.90K
SEK
Data as of
Jun 2019
Most recent filing
Annual Capital Reinvestment Ratio for SynAct Pharma AB (None–None)
Year-by-year Capital Reinvestment Ratio for SynAct Pharma AB from None to None. For live market cap and broader valuation context, see SynAct Pharma AB stock valuation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow